Skip directly to content

There is no one-size-fits-all approach to EtE initiation and implementation, although there are some commonalities across plans. Successful planning usually involves partnership and shared leadership between community leaders, activists, service providers, representatives from academic institutions, and public health officials. Frequently, the first step is setting up an initial large planning meeting to establish community leadership, develop partnerships with other key stakeholders, and develop a plan of action for drafting a broader EtE plan.

TAG is working closely with community advocates and other key stakeholders in four different southern jurisdictions to develop EtE plans for their city or state. Each location was chosen based upon discussions with 45 advocates and key stakeholders from across the Deep South that TAG hosted in May of 2017.

For more on the information presented and findings of that meeting, you can find the meeting report here

Click on these icons for more information about each location and the work they’re doing to end their epidemics

Nashville, TN

Jackson, MS

Louisiana

Alabama

The context, planning, and implementation of each EtE initiative can vary tremendously depending on location. Here are four discussions with key community activists from four different EtE initiatives looking at how their plan was initiated, what the planning process looked like, and how their plans are being implemented:

(VIDEOS)
New York

Minnesota
Houston
Arizona

In 2013, New York community leaders, in partnership with city and state public health officials, began convening town hall discussions to build momentum for an initiative to end HIV/AIDS as an epidemic in the state. Working closely with Governor Cuomo’s office, in 2014, New York became the first jurisdiction in the world to announce an EtE plan built around TasP, PrEP, and increased testing.[i] Since then, several other cities, counties, and states in the United States have made similar announcements.

Here are the EtE jurisdictions as of August 2017 (click on the location to be sent to their

Does ending the epidemic still matter for our communities?

One in two black gay and bisexual men and one in four Latino gay and bisexual men in the United States may become HIV positive in their lifetime.[i] As many as 50% of black transgender women may be living with HIV in America.[ii] People living with HIV remain at increased risk of homelessness, poverty, depression, anxiety, imprisonment, and death. New infections lead to unnecessary and burdensome systemic medical costs.[iii] Our communities remain divided by a virus and the stigma that comes with it.

Ending HIV/AIDS matters just as

HIV science has undergone a renaissance in the past decade. Three powerful tools are leading the way:

Treatment as Prevention (TasP): We have compelling evidence that when a person living with HIV/AIDS is successfully treated and reaches an “undetectable” viral load, their risk of passing the virus on to someone else is negligible—essentially non-existent. In three large studies, HPTN 052, PARTNERS, and Opposites Attract, there were no cases of someone with an undetectable viral load transmitting HIV.[i][ii] Essentially, this means that if every single person living with HIV were diagnosed and

There are different ways to define the end of an HIV epidemic; all of them involve drastic declines in new infections in key populations. Here are a few terms you might need to know in order to understand common objectives and targets for EtE plans:

Prevalence: HIV prevalence refers to the number of people living with HIV at a specific point in time.[i] Ever since effective treatment for HIV was developed, this number has continued to rise due to decreased mortality and ongoing new infections.

We now have evidence-based tools for HIV treatment and prevention that are so effective that they could conceivably end the most deadly infectious disease epidemic in modern history.

Many community leaders across the United States are calling for just that: an end to the HIV/AIDS epidemic in their cities, their counties, and their states.

Higher Funding for TB Research Signals Hope, but Governments Must Dramatically Increase Spending to End TB

Higher Funding for TB Research Signals Hope, but Governments Must Dramatically Increase Spending to End TB

Before the World Health Organization Global Ministerial Conference on Ending TB in the Sustainable Development Era, advocates call on all countries to increase support for TB research to reach global targets.

FOR IMMEDIATE RELEASE 

CONTACT
Mike Frick, Treatment Action Group, +1.347.691.6372
mike.frick@treatmentactiongroup.org

NEW YORK, NOVEMBER 8, 2017—Global funding for tuberculosis (TB) research reached a previously unreported high of $726 million in 2016, according to a report

The Ascent Begins: Tuberculosis Research Funding Trends, 2005–2016

NOVEMBER 8, 2017

By Mike Frick


The world spent $726 million on tuberculosis (TB) research in 2016, marking the first time annual spending has exceeded $700 million since TAG began tracking funding in 2005. Although this figure is $105 million above 2015 levels, it remains woefully inadequate when judged against the innovation gaps holding back the TB response and the ambitious global goals to end the TB epidemic by 2030.

TAG is releasing its latest report —The Ascent Begins: Tuberculosis Research Funding Trends, 2005-2016 —a week before

Pages